CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Cancer Epidemiology Biomarkers & Prevention 17, 758-767, April 1, 2008. Published Online First April 1, 2008;
doi: 10.1158/1055-9965.EPI-07-2855
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1055-9965.EPI-07-2855v1
17/4/758    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Vernon, S. W.
Right arrow Articles by Fernandez, M. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vernon, S. W.
Right arrow Articles by Fernandez, M. E.
Related Collections
Right arrow Early Detection
Right arrow Early Detection: Biomarkers: Discovery, Methodology, Validation

Reliability and Validity of a Questionnaire to Measure Colorectal Cancer Screening Behaviors: Does Mode of Survey Administration Matter?

Sally W. Vernon1, Jasmin A. Tiro2, Rachel W. Vojvodic1, Sharon Coan1, Pamela M. Diamond1, Anthony Greisinger3 and Maria E. Fernandez1

1 University of Texas-Houston School of Public Health, Division of Health Promotion and Behavioral Sciences, Center for Health Promotion and Prevention Research, Houston, Texas; 2 University of Texas Southwest Medical Center, Division of Behavioral and Communication Sciences, Department of Clinical Services, Dallas, Texas; and 3 Kelsey Research Foundation, Houston, Texas

Requests for reprints: Sally W. Vernon, University of Texas-Houston School of Public Health, Division of Health Promotion and Behavioral Sciences, 7000 Fannin Street, Suite 2560, Houston, TX 77030. Phone: 713-500-9760; Fax: 713-500-9750. E-mail: sally.w.vernon{at}uth.tmc.edu

Valid and reliable self-report measures of cancer screening behaviors are important for evaluating efforts to improve adherence to guidelines. We evaluated test-retest reliability and validity of self-report of the fecal occult blood test (FOBT), sigmoidoscopy (SIG), colonoscopy (COL), and barium enema (BE) using the National Cancer Institute colorectal cancer screening (CRCS) questionnaire. A secondary objective was to evaluate reliability and validity by mail, telephone, and face-to-face survey administration modes. Consenting men and women, 51 to 74 years old, receiving care at a multispecialty clinic for at least 5 years who had not been diagnosed with colorectal cancer were stratified by prior CRCS status and randomized to survey mode (n = 857). Within survey mode, respondents were randomized to complete a second survey at 2 weeks, 3 months, or 6 months. Comparing self-report with administrative and medical records, concordance estimates were 0.91 for COL, 0.85 for FOBT, 0.85 for SIG, and 0.92 for BE. Overall sensitivity estimates were 0.91 for COL, 0.82 for FOBT, 0.76 for SIG, and 0.56 for BE. Specificity estimates were 0.91 for COL, 0.86 for FOBT, 0.89 for SIG, and 0.97 for BE. Sensitivity and specificity varied little by survey mode for any test. Report-to-records ratio showed overreporting for SIG (1.1), COL (1.15), and FOBT (1.57), and underreporting for BE (0.82). Reliability at all time intervals was highest for COL; there was no consistent pattern according to survey mode. This study provides evidence to support the use of the National Cancer Institute CRCS questionnaire to assess self-report with any of the three survey modes. (Cancer Epidemiol Biomarkers Prev 2008;17(4):758–67)




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. M. Jones, S. J. Mongin, D. Lazovich, T. R. Church, and M. W. Yeazel
Validity of Four Self-reported Colorectal Cancer Screening Modalities in a General Population: Differences over Time and by Intervention Assignment
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 777 - 784.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. G. Zapka
Validation of Colorectal Cancer Screening Behaviors
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 745 - 747.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.